In a 41-year-old man with granulomatosis with polyangiitis, is his grandmother considered a relative or a disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

This is a Disease, Not a Relative

Granulomatosis with polyangiitis (GPA) is a systemic autoimmune vasculitis—it is the patient's disease diagnosis, not his grandmother. The question appears to contain a fundamental misunderstanding about the nature of GPA.

What Granulomatosis with Polyangiitis Actually Is

GPA (formerly Wegener's granulomatosis) is an ANCA-associated vasculitis characterized by necrotizing granulomatous inflammation affecting small- and medium-sized vessels 1. It typically manifests with:

  • Upper respiratory tract involvement: Persistent bleeding, crusting, nasal obstruction, septal perforation 1
  • Pulmonary manifestations: Nodules, cavitary lesions, alveolar hemorrhage 2, 3
  • Renal disease: Rapidly progressive glomerulonephritis 4, 5
  • Systemic features: Fever, weight loss, arthralgias 2, 3

The disease is strongly associated with PR3-ANCA antibodies (positive in 80-90% of cases) 1.

Addressing the Familial Risk Question

If the underlying concern is whether the patient's grandmother could develop GPA or whether there's a family history component, the evidence shows:

Familial clustering of GPA is extremely rare. A large Swedish population-based study found only 2 cases of GPA among 6,670 first-degree relatives of patients with GPA, yielding a relative risk of just 1.56 (95% CI 0.35-6.90)—essentially no significant increase 6. The absolute occurrence among close biological relatives is low 6.

While some genetic susceptibility exists (HLA-DRB1, CTLA4, PTPN22 genes) 7, and rare case reports document familial cases 8, GPA does not show pronounced familial aggregation like lupus or inflammatory bowel disease 6.

Clinical Implications for This Patient

For the 41-year-old man with GPA:

  • His diagnosis requires treatment with immunosuppression (rituximab or cyclophosphamide for induction, followed by maintenance therapy) 5, 9
  • His family members have minimal increased risk and do not require screening 6
  • The disease itself—not family history—drives prognosis and management decisions

The grandmother is a relative. Granulomatosis with polyangiitis is the disease.

Related Questions

Can a cavitary lung lesion be a manifestation of granulomatosis with polyangiitis?
What are the causes of Granulomatosis with Polyangiitis (GPA)?
What is the recommended follow‑up schedule and monitoring for a patient with granulomatosis with polyangiitis?
Do families have a predisposition to PR3‑positive ANCA‑associated vasculitis (granulomatosis with polyangiitis) given that my brother and sister both have saddle‑nose deformity and are PR3‑positive?
What is the recommended initial treatment for ANCA‑associated vasculitis presenting with mild hemoptysis, persistent pulmonary infiltrates, and proteinuria?
What is the recommended treatment for metastatic breast cancer with liver metastases that is estrogen‑receptor (ER) and progesterone‑receptor (PR) negative and HER2 (human epidermal growth factor receptor 2) positive?
In a patient with alcohol abuse, blood pressure 138/90 mm Hg, and anxiety‑related sweating, what is the appropriate immediate management?
What are the indications, dosing regimen, administration method, contraindications, common adverse effects, and monitoring recommendations for talimogene laherparepvec (T‑VEC) in patients with unresectable melanoma?
When can I safely relax and watch television after being off lurasidone (Latuda) 40 mg for seven days?
What is the appropriate diazepam dosing regimen for an alcoholic patient presenting with anxiety?
Which genomic mutations should be tested in a patient with metastatic triple‑negative breast cancer who is not tolerating sacituzumab well?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.